Epidural Blood Patch for Postdural Puncture Headache in a Patient With Coronavirus Disease 2019: A Case Report

Mark C Norris1, Albert Kalustian, Seroos Salavati

  • 1From the Department of Anesthesiology, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts.

A&A Practice
|August 27, 2020
PubMed

Insights

The safety of epidural blood patch for treating headaches after spinal anesthesia in COVID-19 patients is unknown. This case study shows successful headache relief and no neurological symptoms in a patient with coronavirus disease 2019.

Area of Science:

  • Anesthesiology
  • Neurology
  • Infectious Diseases

Background:

  • The safety of epidural blood patch (EBP) in patients with coronavirus disease 2019 (COVID-19) remains unestablished.
  • Postdural puncture headache (PDPH) is a potential complication following spinal anesthesia, commonly treated with EBP.

Observation:

  • A case report details a patient who underwent cesarean delivery with spinal anesthesia and subsequently developed PDPH.
  • The patient was diagnosed with COVID-19.
  • An epidural blood patch was administered to manage the PDPH.

Findings:

  • The epidural blood patch effectively resolved the patient's postdural puncture headache.
  • No adverse neurological events or complications related to COVID-19 or the procedure were observed post-treatment.

Implications:

  • This case suggests that epidural blood patch may be a safe and effective treatment for PDPH in patients with COVID-19.
  • Further research is warranted to confirm the safety and efficacy of EBP in this patient population.
  • This finding could inform clinical practice regarding PDPH management in pregnant patients with active SARS-CoV-2 infection.

Related Concept Videos